Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Aug-2025 | 3,740.9 | 3,740.9 | 3,642 | 3,678.2 | 49,704 | 2,22,40,63,943.6 | 4,10,859 |
04-Aug-2025 | 3,658.3 | 3,675.5 | 3,604.4 | 3,612.8 | 39,088 | 1,47,62,92,401.2 | 2,45,013 |
05-Aug-2025 | 3,612.5 | 3,631.8 | 3,583.5 | 3,589.2 | 40,650 | 1,01,37,91,492.9 | 1,64,481 |
06-Aug-2025 | 3,580.1 | 3,591.1 | 3,516.1 | 3,524.1 | 43,726 | 91,23,96,058.9 | 1,31,970 |
07-Aug-2025 | 3,490.2 | 3,637 | 3,490.2 | 3,596.7 | 45,835 | 1,43,55,36,442.1 | 1,95,220 |
08-Aug-2025 | 3,600 | 3,619.2 | 3,562.8 | 3,573.2 | 36,514 | 64,07,37,065.4 | 1,02,161 |
11-Aug-2025 | 3,573.2 | 3,620.1 | 3,558 | 3,614.9 | 18,414 | 45,21,02,361.5 | 86,381 |
12-Aug-2025 | 3,614.9 | 3,641.8 | 3,591.7 | 3,626.1 | 19,667 | 83,41,41,760.9 | 1,31,993 |
13-Aug-2025 | 3,629.7 | 3,652.3 | 3,604 | 3,617.8 | 32,000 | 1,04,16,01,933.8 | 2,05,548 |
14-Aug-2025 | 3,621.3 | 3,647.7 | 3,593.9 | 3,623 | 24,387 | 1,38,76,40,804.4 | 2,99,146 |
18-Aug-2025 | 3,645.5 | 3,675 | 3,587.2 | 3,651.6 | 35,272 | 1,87,00,06,983.1 | 4,15,234 |
19-Aug-2025 | 3,660.8 | 3,663.8 | 3,625 | 3,651.6 | 25,825 | 71,86,96,147.9 | 1,32,402 |
20-Aug-2025 | 3,666 | 3,672.7 | 3,648.2 | 3,663.8 | 31,546 | 84,52,44,445.4 | 1,66,493 |
21-Aug-2025 | 3,666 | 3,683.6 | 3,628.6 | 3,647.4 | 19,886 | 56,94,98,052.7 | 89,994 |
22-Aug-2025 | 3,643 | 3,698 | 3,635 | 3,685.3 | 36,399 | 1,02,77,06,905.3 | 1,94,840 |
25-Aug-2025 | 3,689.9 | 3,700 | 3,654.1 | 3,674.5 | 46,056 | 99,39,45,241.7 | 1,74,093 |
26-Aug-2025 | 3,673.4 | 3,673.4 | 3,580.2 | 3,604.8 | 51,529 | 1,82,38,62,882 | 3,16,247 |
28-Aug-2025 | 3,636 | 3,636 | 3,568.2 | 3,576.9 | 25,406 | 50,83,55,544.1 | 69,350 |
29-Aug-2025 | 3,575 | 3,607.6 | 3,553.3 | 3,559.8 | 37,300 | 99,75,46,562.4 | 1,93,641 |
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
